SSE: 1349 - Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.

Yield per half year: 0%
Sector: Healthcare

Reporting Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.

Capitalization

IFRS
Reporting Annual
LTM 5 year average CAGR 5
Капитализация, млрд ¥
8.24
Выручка, млрд ¥
1.28
Чистая прибыль, млрд ¥
0.2424
EV, млрд ¥
6.98
EBITDA, млрд ¥
0.3228


Balance sheet

IFRS
Reporting Annual
LTM 5 year average CAGR 5
Наличность, млрд ¥
1.23
Долг, млрд ¥
0.1193


Share

IFRS
Reporting Annual
LTM 5 year average CAGR 5
EPS 0.15


Efficiency

IFRS
Reporting Annual
2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROE, % 10.9 7.85
ROA, % 5.94 4.30
ROS, % 18.94 18.94 18.94 18.94 8.11
Рентаб EBITDA, % 21.22 5.09
Чистая рентаб, % 18.9 8.10
Operation Margin, % 0 0 0 0 4.29


Coefficients

IFRS
Reporting Annual
2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/E
10.26 36.76
P/BV
1.11 3.67
P/S
1.93 13.01
P/FCF
0 0 0 0 7.85
E/P
0.0294 0.0294 0.0294 0.0294 0.03
EV/EBITDA
20.56 19.30
EV/Ebit
0 0 0
EV/S
5.45 5.45 5.45 5.45 59.91
EV/FCF
0 0 0 4.07
Debt/EBITDA
0.3696 0.3696 0.3696 0.3696 1.91
Netdebt/Ebitda
0 0 0 0 0.24
Debt/Ratio
0 0 0 0 0.07
Debt/Equity
0 0 0 0 0.14
Debt/Net Income
0.4922 0.4922 0.4922 0.4922 3.99
Бета
0 0 0 0 0.56
Индекс Альтмана
0 0 0 0 7.34


Dividends

IFRS
Reporting Annual
LTM Industry average 5 year average CAGR 5
Дивиденд
0.08
Див доход, ао, %
3.06 0.81
Дивиденды / прибыль, %
54.83 41.32


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual
2023 CAGR 5
Персонал, чел
910